Neurology Devices Market Analysis By Product (Neurostimulation, Interventional Neurology, CSF Management, Spinal Cord Stimulation, Deep Brain Stimulation, Embolization, Neurovascular Catheters, Cerebral Angioplasty & Stents, CSF Shunts, Ultrasonic Aspirators, Stereotactic Systems) And Segment Forecasts To 2022

Published: Aug, 2014 | Pages: 87 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

Global neurology devices market is expected to reach USD 10.8 billion by 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to growing need for development of different neurostimulation techniques with efficient and accurate algorithms for treatment of several CNS associated disorders.

Rise in incidence of cerebral stroke and other severe disorders such as Alzheimer's disease, epilepsy, and Parkinsonism is expected to fuel demand of neurology devices thereby driving industry growth. According to National Institute of Neurological Disorders and Stroke (NINDS), approximately 50 million Americans are affected due to these disorders leading to high economic & disease costs burden for medical expenses coupled with loss of productivity. The industry is expected to witness a considerable increase in demand for CNS related therapeutic procedures over the forecast period.

Further key findings from the study suggest:

Neurostimulation devices accounted for over 50% of the revenue generated in the market for 2014. This large share can be attributed to the growing number of chronic CNS disorders, a globally ageing population and development of minimally invasive neurological and faster acting stimulation devices that attract higher market usage and penetration in the neurology devices market.

Neurosurgery segment including ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips are expected to witness considerable growth over the forecast period due to their essential nature of use in tumor removal and brain cell damage repair surgeries.

North America dominated the market in 2014, with revenue estimated at over USD 2,400 million. Presence of sophisticated healthcare infrastructure, favorable government initiatives pertaining to pharmaceutical R&D, cancer research, neurological R&D investment, and the presence of a considerably large CNS disorder patient base are some drivers of this market.

Asia Pacific is expected to witness lucrative CAGR of over 8.0% from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment, and growing medical expenditures in emerging economies such as India and China. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in neuro-informatics and high untapped market opportunities are the important factors accounting for the expected growth of market in this region over the forecast period.

Key participants of the neurology devices market include Johnson and Johnson, B.Braun Melsungen AG, Boston Scientific Corporation, St. Jude Medical Inc Covidien PLC, Medtronic Inc., Johnson & Johnson, Magstim Co Ltd., W.L. Gore & Associates Inc., Integra Life Sciences Holdings Corp., Stryker Corp.

Market participants are involved in R&D for development of advanced stimulation and neuromodulation techniques with minimally invasive procedures that are more preferable to the patients. Furthermore, collaborations with university as well as non-university based institutes that are engaged in neuroscience research are expected to boost sector growth in the coming years.

 Table of Contents


Chapter 1 Methodology and Scope
                  1.1 Research Methodology
                  1.2 Research Scope & Assumptions
                  1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Neurology Devices Industry Outlook
                  3.1 Market segmentation
                  3.2 Market size and growth prospects, 2012 - 2022
                  3.3 Neurology devices market dynamics
                        3.3.1 Market driver analysis
                                3.3.1.1 Technological advances driving growth
                                3.3.1.2 Growing base of aging population more prone to chronic diseases such as Parkinson's and Alzheimer's disorders
                                3.3.1.3 Increasing demand for minimally invasive surgeries
                                3.3.1.4 Rising number of stroke patients
                        3.3.2 Market restraint analysis
                                3.3.2.1 Rising intricacies of clinical trials
                                3.3.2.2 Hospital budget constraints & alternative treatment facilities
                  3.4 Key opportunities prioritized, 2014
                  3.5 Industry analysis - Porter's
                  3.6 Neurology devices PESTEL Analysis
Chapter 4 Neurology Devices Product Outlook
                  4.1 Global neurology devices revenue share, by product, 2014 & 2022
                  4.2 Neurostimulation
                        4.2.1 Neurostimulation market, 2012 - 2022 (USD Million)
                        4.2.2 Spinal cord stimulation devices
                                4.2.2.1 Spinal cord stimulation devices market, 2012 - 2022 (USD Million)
                        4.2.3 Deep brain stimulation devices
                                4.2.3.1 Deep brain stimulation devices market, 2012 - 2022 (USD Million)
                        4.2.4 Sacral nerve stimulation
                                4.2.4.1 Sacral nerve stimulation market, 2012 - 2022 (USD Million)
                        4.2.5 Vagus nerve stimulation
                                4.2.5.1 Vagus nerve stimulation market, 2012 - 2022 (USD Million)
                        4.2.6 Gastric electric stimulation
                                4.2.6.1 Gastric electric stimulation market, 2012 - 2022 (USD Million)
                  4.3 Interventional neurology
                        4.3.1 Interventional neurology market, 2012 - 2022 (USD Million)
                        4.3.2 Aneurysm coiling & embolization
                                4.3.2.1 Aneurysm coiling & embolization market, 2012 - 2022 (USD Million)
                                4.3.2.2 Embolic coils
                                        4.3.2.2.1 Embolic coils market, 2012 - 2022 (USD Million)
                                4.3.2.3 Flow diversion devices
                                        4.3.2.3.1 Flow diversion devices market, 2012 - 2022 (USD Million)
                                4.3.2.4 Liquid embolic agents
                                        4.3.2.4.1 Liquid embolic agents market, 2012 - 2022 (USD Million)
                        4.3.3 Neurovascular catheters
                                4.3.3.1 Neurovascular catheters market, 2012 - 2022 (USD Million)
                                4.3.3.2 Micro catheters
                                        4.3.3.2.1 Micro catheters market, 2012 - 2022 (USD Million)
                                4.3.3.3 Micro guide wires
                                        4.3.3.3.1 Micro guide wires market, 2012 - 2022 (USD Million)
                        4.3.4 Cerebral balloon angioplasty & stenting
                                4.3.4.1 Cerebral balloon angioplasty & stenting market, 2012 - 2022 (USD Million)
                                4.3.4.2 Carotid artery stents
                                        4.3.4.2.1 Carotid artery stents market, 2012 - 2022 (USD Million)
                                4.3.4.3 Filter devices
                                        4.3.4.3.1 Filter devices market, 2012 - 2022 (USD Million)
                                4.3.4.4 Balloon occlusion devices
                                        4.3.4.4.1 Balloon occlusion devices market, 2012 - 2022 (USD Million)
                        4.3.5 Neurothrombectomy
                                4.3.5.1 Neurothrombectomy market, 2012 - 2022 (USD Million)
                                4.3.5.2 Clot retriever
                                        4.3.5.2.1 Clot retriever market, 2012 - 2022 (USD Million)
                                4.3.5.3 Suction aspiration devices
                                        4.3.5.3.1 Suction aspiration devices market, 2012 - 2022 (USD Million)
                                4.3.5.4 Snares
                                        4.3.5.4.1 Snares market, 2012 - 2022 (USD Million)
                  4.4 CSF management
                        4.4.1 CSF management market, 2012 - 2022 (USD Million)
                        4.4.2 CSF shunts
                                4.4.2.1 CSF shunts devices market, 2012 - 2022 (USD Million)
                        4.4.3 CSF drainage
                                4.4.3.1 CSF drainage market, 2012 - 2022 (USD Million)
                  4.5 Neurosurgery devices
                        4.5.1 Neurosurgery devices market, 2012 - 2022 (USD Million)
                        4.5.2 Ultrasonic aspirators
                                4.5.2.1 Ultrasonic aspirators devices market, 2012 - 2022 (USD Million)
                        4.5.3 Stereotactic systems
                                4.5.3.1 Stereotactic systems market, 2012 - 2022 (USD Million)
                        4.5.4 Neuroendoscopes
                                4.5.4.1 Neuroendoscopes market, 2012 - 2022 (USD Million)
                        4.5.5 Aneurysm clips
                                4.5.5.1 Aneurysm clips market, 2012 - 2022 (USD Million)
Chapter 5 Neurology Devices Regional Outlook
                  5.1 Neurology devices revenue share, by region, 2014 & 2022
                  5.2 North America
                        5.2.1 North America neurology devices market, 2012 - 2022 (USD Million)
                  5.3 Europe
                        5.3.1 Europe neurology devices market, 2012 - 2022 (USD Million)
                  5.4 Asia Pacific
                        5.4.1 Asia Pacific neurology devices market, 2012 - 2022 (USD Million)
                  5.5 RoW
                        5.5.1 RoW neurology devices market, 2012 - 2022 (USD Million)
Chapter 6 Competitive Landscape
                  6.1 B. Braun Melsungen AG
                        6.1.1 Company Overview
                        6.1.2 Financial Performance
                        6.1.3 Product Benchmarking
                        6.1.4 Strategic Initiatives
                  6.2 Boston Scientific Corporation
                        6.2.1 Company Overview
                        6.2.2 Financial Performance
                        6.2.3 Product Benchmarking
                        6.2.4 Strategic Initiatives
                  6.3 Covidien PLC
                        6.3.1 Company Overview
                        6.3.2 Financial Performance
                        6.3.3 Product Benchmarking
                        6.3.4 Strategic Initiatives
                  6.4 Integra LifeSciences Holdings Corporation
                        6.4.1 Company Overview
                        6.4.2 Financial Performance
                        6.4.3 Product Benchmarking
                        6.4.4 Strategic Initiatives
                  6.5 Johnson and Johnson
                        6.5.1 Company Overview
                        6.5.2 Financial Performance
                        6.5.3 Product Benchmarking
                        6.5.4 Strategic Initiatives
                  6.6 Medtronic Inc.
                        6.6.1 Company Overview
                        6.6.2 Financial Performance
                        6.6.3 Product Benchmarking
                        6.6.4 Strategic Initiatives
                  6.7 St. Jude Medical, Inc
                        6.7.1 Company Overview
                        6.7.2 Financial Performance
                        6.7.3 Product Benchmarking
                        6.7.4 Strategic Initiatives
                  6.8 Stryker Corporation
                        6.8.1 Company Overview
                        6.8.2 Financial Performance
                        6.8.3 Product Benchmarking
                        6.8.4 Strategic Initiatives
                  6.9 W.L. Gore & Associates, Inc.
                        6.9.1 Company Overview
                        6.9.2 Financial Performance
                        6.9.3 Product Benchmarking
                        6.9.4 Strategic Initiatives
                  6.10 Magstim Co Ltd.
                        6.10.1 Company Overview
                        6.10.2 Financial Performance
                        6.10.3 Product Benchmarking
                        6.10.4 Strategic Initiatives

List of Tables


TABLE 1 Neurology Devices - Industry Snapshot & Key Buying Criteria, 2012 - 2022
TABLE 2 Global neurology devices market, by product, 2012 - 2022 (USD Million)
TABLE 3 Neurology devices market, by region, 2012 - 2022 (USD Million)
TABLE 4 Biotechnology - Key market driver analysis
TABLE 5 Biotechnology - Key market restraint analysis
TABLE 6 North America neurology devices market, by product, 2012 - 2022 (USD Million)
TABLE 7 North America neurostimulation market, by type, 2012 - 2022 (USD Million)
TABLE 8 North America interventional neurology, by type, 2012 - 2022 (USD Million)
TABLE 9 North America neuro-malformation, by product 2012 - 2022 (USD Million)
TABLE 10 North America neurovascular catheters market, by product, 2012 - 2022 (USD Million)
TABLE 11 North America angioplasty & stenting market, by product, 2012 - 2022 (USD Million)
TABLE 12 North America neurothrombectomy market, by product, 2012 - 2022 (USD Million)
TABLE 13 North America CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 14 North America neurosurgery market, by product, 2012 - 2022 (USD Million)
TABLE 15 Europe neurology devices market, by product, 2012 - 2022 (USD Million)
TABLE 16 Europe neurostimulation market, by type, 2012 - 2022 (USD Million)
TABLE 17 Europe interventional neurology, by type, 2012 - 2022 (USD Million)
TABLE 18 Europe neuro-malformation, by product 2012 - 2022 (USD Million)
TABLE 19 Europe neurovascular catheters market, by product, 2012 - 2022 (USD Million)
TABLE 20 Europe angioplasty & stenting market, by product, 2012 - 2022 (USD Million)
TABLE 21 Europe neurothrombectomy market, by product, 2012 - 2022 (USD Million)
TABLE 22 Europe CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 23 Europe neurosurgery market, by product, 2012 - 2022 (USD Million)
TABLE 24 Asia Pacific neurology devices market, by product, 2012 - 2022 (USD Million)
TABLE 25 Asia Pacific neurostimulation market, by type, 2012 - 2022 (USD Million)
TABLE 26 Asia Pacific interventional neurology, by type, 2012 - 2022 (USD Million)
TABLE 27 Asia Pacific neuro-malformation, by product 2012 - 2022 (USD Million)
TABLE 28 Asia Pacific neurovascular catheters market, by product, 2012 - 2022 (USD Million)
TABLE 29 Asia Pacific angioplasty & stenting market, by product, 2012 - 2022 (USD Million)
TABLE 30 Asia Pacific neurothrombectomy market, by product, 2012 - 2022 (USD Million)
TABLE 31 Asia Pacific CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 32 Asia Pacific neurosurgery market, by product, 2012 - 2022 (USD Million)
TABLE 33 RoW neurology devices market, by product, 2012 - 2022 (USD Million)
TABLE 34 RoW neurostimulation market, by type, 2012 - 2022 (USD Million)
TABLE 35 RoW interventional neurology, by type, 2012 - 2022 (USD Million)
TABLE 36 RoW neuro-malformation, by product 2012 - 2022 (USD Million)
TABLE 37 RoW neurovascular catheters market, by product, 2012 - 2022 (USD Million)
TABLE 38 RoW angioplasty & stenting market, by product, 2012 - 2022 (USD Million)
TABLE 39 RoW neurothrombectomy market, by product, 2012 - 2022 (USD Million)
TABLE 40 RoW CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 41 RoW neurosurgery market, by product, 2012 - 2022 (USD Million)